维普期刊资源整合服务平台（V6.5）

68篇 您的检索式：作者名="Cooper MR"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase显示文摘	Capizzi RL Poole M Cooper MR	1984	Blood1984，63，3：	1
2	In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole显示文摘	Cooper CR Jr McGinnis MR	1996	Am J Obstet Gynecol1996，175，6：	1
3	Prostatic specific antigen and the prediction of prognosis in metastatic cancer显示文摘	Armitage TG Robinson MR	1990	Cancer1990，66，5：	1
4	Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin显示文摘	Baselga J Pfister D Cooper MR	2000	J Clin Oncol2000，18，4：	1
5	Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin 显示文摘	Baselga J Pfister D Cooper MR	2000	J Clin Oncol2000，18，4：	1
6	Delineation of the thymic and bursal lymphoid systems in the chicken显示文摘	Cooper MR Peterson Good R	1965	Nature1965，205，：	1
7	Ceritinib: a new tyrosine kinase inhibitor for non-small-cell-lung cancer显示文摘	Cooper MR Chim H Chan H	2015	Ann Pharmacother2015，49，1：	1
8	Antecedents and outcomes of work-family conflict: testing a model of the work-family interface 显示文摘	Frone MR Russell M Cooper ML	1992	J Appl Psychol1992，77，1：	1
9	Phase Ⅰ studies of antiepidermal growth factor receptor chimeric antibody C225 alone andin combination with cisplatin显示文摘	Baselga J Pilster D Cooper MR	2000	Clin Oncol2000，18，4：	1
10	Lipids and diabetic renal disease 显示文摘	Cooper MR Jandeleit Dahm KA	2005	Curr Dia Rep2005，5，6：	1
11	Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin显示文摘	Baselga J Pfister D Cooper MR	2000	J Clin Oncol2000，18，4：	1
12	Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin显示文摘	Baselga J Pfister D Cooper MR	2000	J Clin Oncol2000，18，4：	1
13	Liplds and diabetic renal dlsease显示文摘	Cooper MR Jandeleit-Dahm KA	2005	Curr Dia Rep2005，5，6：	1
14	Metabolic derangements in the insulin-resistant heart 显示文摘	Govindarajan G Hayden MR Cooper SA	2006	Cardiometab Syndr2006，1，2：	1
15	Hyperactivity and dopamine D 1 receptor activation in mice lacking girk2 channels显示文摘	Blednov YA Stoffel MR Cooper M	2002	Psychopharmacology2002，159，4：	1
16	Ceritinib: a new tyrosine kinase inhibitor for non-small-cell lung cancer 显示文摘	Cooper MR Chim H Chart H	2015	Ann Phar- macother2015，49，：	1
17	Phase Ⅰ studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin 显示文摘	Baselga J Pfister D Cooper MR	2000	J Clin Oncol2000，18，：	1
18	Rings of charge within the extracellular vestibule influence ion permeation of the 5-HT3A receptor显示文摘	Livesey MR Cooper MA Lambert JJ	2011	J Biol Chem2011，286，16：	1
19	Phase I studies of anti-ep idermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin显示文摘	Baselga J Pfister D Cooper MR	2000	J Clin Oncol2000，18，4：	1
20	Assessment and management of hypertension in transplant patients 显示文摘	Weir MR Burgess ED Cooper JE	2015	J Am Soe Nephrol2015，，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示